Seven scientists at UCL will take on some of the toughest obstacles in cancer
Seven scientists at UCL will take on some of the toughest obstacles in cancer - Seven scientists at UCL will take on some of the toughest obstacles in cancer, after being selected to play leading roles in the latest global Cancer Grand Challenges. Set up by Cancer Research UK and the National Cancer Institute in the US (part of the National Institutes of Health), Cancer Grand Challenges aims to drive progress against major research and treatment hurdles, by setting 'challenges' and bringing diverse, international teams together to think differently. Today (June 16), Cancer Grand Challenges announced four new teams of scientific investigators who will each receive £20m. UCL researchers are represented in three of the four teams and will receive £11.97m in total, over the next five years. Dr Martin Pule (UCL Cancer Institute) will co-lead the NexTGen team, which takes on the 'Solid tumours in children' challenge. He will be joined by UCL co-investigators Professor Karen Page (UCL Mathematics), Dr Karin Straathof (UCL Great Ormond Street Institute of Child Health), Professor Sergio Quezada and Dr Kevin Litchfield (both UCL Cancer Institute) and Professor Marc-Olivier Coppens (UCL Chemical Engineering). The team, co-led by the US Children's National Hospital's Catherine Bollard and with 23 investigators across the UK, US and France, will work to develop next-generation immunotherapies for children with solid cancers.
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.
